ARTICLE | Distillery Therapeutics
Infectious disease
March 20, 2018 11:06 PM UTC
In vitro and cell culture studies identified triazolopyrimidinone- and azabenzimidazole-based bacterial coaD inhibitors that could help treat Gram-negative bacterial infection. Fragment-based screenin...
BCIQ Company Profiles
BCIQ Target Profiles